HomeGLABF • OTCMKTS
add
Gemina Laboratories Ltd
Previous close
$0.40
Year range
$0.28 - $0.70
Market cap
33.00M CAD
Avg Volume
1.75K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.04M | -46.95% |
Net income | -761.66K | 61.06% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.03M | 47.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 990.00 | -98.81% |
Total assets | 1.46M | -22.33% |
Total liabilities | 3.04M | 56.23% |
Total equity | -1.59M | — |
Shares outstanding | 73.33M | — |
Price to book | -20.04 | — |
Return on assets | -165.43% | — |
Return on capital | 409.95% | — |
Cash Flow
Net change in cash
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -761.66K | 61.06% |
Cash from operations | 8.26K | 102.50% |
Cash from investing | 16.26K | 103.58% |
Cash from financing | -26.42K | -109.36% |
Net change in cash | -1.91K | 99.62% |
Free cash flow | 367.73K | -34.29% |
About
Founded
2017
Headquarters
Website
Employees
6